Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/76863
DC Field | Value | Language |
---|---|---|
dc.contributor | Department of Applied Biology and Chemical Technology | - |
dc.contributor | Innovation and Technology Development Office | - |
dc.creator | Chan, TH | en_US |
dc.creator | Wang, CC | en_US |
dc.date.accessioned | 2018-06-15T02:11:37Z | - |
dc.date.available | 2018-06-15T02:11:37Z | - |
dc.identifier.uri | http://hdl.handle.net/10397/76863 | - |
dc.language.iso | en | en_US |
dc.rights | Assignee: The Hong Kong Polytechnic University | en_US |
dc.rights | Assignee: The Chinese University of Hong Kong | en_US |
dc.title | Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) for use in the treatment of endometriosis | en_US |
dc.type | Patent | en_US |
dc.description.otherinformation | US9713603; US9713603 B2; US9713603B2; US9,713,603; US 9,713,603 B2; 9713603; Appl. No. 14/422,642 | en_US |
dcterms.abstract | Method of treating endometriosis and related indications, comprising the administration of Pro-EGCG, a synthetic and derivative product of epigallocatechin-3-gallate [(-)-EGCG]. Use of Pro-EGCG in the manufacture of a medicament for treating endometriosis and related indications. Pro-EGCG for use in the treatment of endometriosis and related indications. | - |
dcterms.bibliographicCitation | US Patent 9,713,603 B2. Washington, DC: US Patent and Trademark Office, 2017. | en_US |
dcterms.issued | 2017-07-25 | - |
dc.identifier.ros | 2016002236 | - |
dc.description.country | US | - |
dc.description.validate | 201806 bcrc | - |
dc.description.oa | Version of Record | en_US |
Appears in Collections: | Patent |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
us9713603b2.pdf | 1.55 MB | Adobe PDF | View/Open |
Page views
83
Last Week
1
1
Last month
Citations as of May 4, 2025
Downloads
56
Citations as of May 4, 2025

Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.